224 related articles for article (PubMed ID: 24452947)
1. Increased apoptosis induction in CD4+ CD25+ Foxp3+ T cells contributes to enhanced disease activity in patients with rheumatoid arthritis through IL-10 regulation.
Li N; Ma T; Han J; Zhou J; Wang J; Zhang J; Zheng S
Eur Rev Med Pharmacol Sci; 2014; 18(1):78-85. PubMed ID: 24452947
[TBL] [Abstract][Full Text] [Related]
2. (99) Tc-methylene diphosphonate improves rheumatoid arthritis disease activity by increasing the frequency of peripheral γδ T cells and CD4(+) CD25(+) Foxp3(+) Tregs.
Su D; Shen M; Gu B; Wang X; Wang D; Li X; Sun L
Int J Rheum Dis; 2016 Jun; 19(6):586-93. PubMed ID: 24467668
[TBL] [Abstract][Full Text] [Related]
3. APL-1, an altered peptide ligand derived from human heat-shock protein 60, selectively induces apoptosis in activated CD4+ CD25+ T cells from peripheral blood of rheumatoid arthritis patients.
Barberá A; Lorenzo N; Garrido G; Mazola Y; Falcón V; Torres AM; Hernández MI; Hernández MV; Margry B; de Groot AM; van Roon J; van der Zee R; Broere F; van Eden W; Padrón G; Domínguez Mdel C
Int Immunopharmacol; 2013 Dec; 17(4):1075-83. PubMed ID: 24177275
[TBL] [Abstract][Full Text] [Related]
4. CD4+CD25(high)CD127(low/-) Treg cell frequency from peripheral blood correlates with disease activity in patients with rheumatoid arthritis.
Kawashiri SY; Kawakami A; Okada A; Koga T; Tamai M; Yamasaki S; Nakamura H; Origuchi T; Ida H; Eguchi K
J Rheumatol; 2011 Dec; 38(12):2517-21. PubMed ID: 21921095
[TBL] [Abstract][Full Text] [Related]
5. [Impaired apoptosis of peripheral blood CD4+T cells in patients with rheumatoid arthritis].
Cao Y; Liu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May; 31(5):682-5, 688. PubMed ID: 25940298
[TBL] [Abstract][Full Text] [Related]
6. [Study on expressions of CD25 and CD127 in CD4+ peripheral T lymphocytes of patients with rheumatoid arthritis].
Huang ZX; Zheng BR; Li TW; Lu YM; Gu JR; Han XY
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2476-80. PubMed ID: 20137434
[TBL] [Abstract][Full Text] [Related]
7. Expression of soluble programmed death-1 protein in peripheral blood regulatory T cells and its effects on rheumatoid arthritis progression.
Ren CF; Zhao YX; Hou CF; Luan L; Duan GQ; Li SJ; Zhao JH
Mol Med Rep; 2017 Jan; 15(1):460-466. PubMed ID: 27909722
[TBL] [Abstract][Full Text] [Related]
8. [Increased percentage and defective inhibitory function of CD4
Zhang R; Miao J; Zhang K; Zheng Z; Zhu P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):961-966. PubMed ID: 31878990
[TBL] [Abstract][Full Text] [Related]
9. A study on relationship among apoptosis rates, number of peripheral T cell subtypes and disease activity in rheumatoid arthritis.
Ji L; Geng Y; Zhou W; Zhang Z
Int J Rheum Dis; 2016 Feb; 19(2):167-71. PubMed ID: 24618356
[TBL] [Abstract][Full Text] [Related]
10. Quantification and phenotype of regulatory T cells in rheumatoid arthritis according to disease activity score-28.
Sempere-Ortells JM; Pérez-García V; Marín-Alberca G; Peris-Pertusa A; Benito JM; Marco FM; Zubcoff JJ; Navarro-Blasco FJ
Autoimmunity; 2009; 42(8):636-45. PubMed ID: 19886735
[TBL] [Abstract][Full Text] [Related]
11. Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab.
Toubi E; Kessel A; Mahmudov Z; Hallas K; Rozenbaum M; Rosner I
Ann N Y Acad Sci; 2005 Jun; 1051():506-14. PubMed ID: 16126991
[TBL] [Abstract][Full Text] [Related]
12. In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression.
Liberal R; Grant CR; Holder BS; Cardone J; Martinez-Llordella M; Ma Y; Heneghan MA; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2015 Sep; 62(3):863-75. PubMed ID: 25953611
[TBL] [Abstract][Full Text] [Related]
13. IL-22+ CD4+ T cells in patients with rheumatoid arthritis.
Zhao L; Jiang Z; Jiang Y; Ma N; Zhang Y; Feng L; Wang K
Int J Rheum Dis; 2013 Oct; 16(5):518-26. PubMed ID: 24164838
[TBL] [Abstract][Full Text] [Related]
14. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
Hiraki S; Ono S; Tsujimoto H; Kinoshita M; Takahata R; Miyazaki H; Saitoh D; Hase K
Surgery; 2012 Feb; 151(2):313-22. PubMed ID: 21982068
[TBL] [Abstract][Full Text] [Related]
15. Numbers of CD25+Foxp3+ T cells that lack the IL-7 receptor are increased intra-articularly and have impaired suppressive function in RA patients.
van Roon JA; Hartgring SA; van der Wurff-Jacobs KM; Bijlsma JW; Lafeber FP
Rheumatology (Oxford); 2010 Nov; 49(11):2084-9. PubMed ID: 20693259
[TBL] [Abstract][Full Text] [Related]
16. Activated T cells complicate the identification of regulatory T cells in rheumatoid arthritis.
Aerts NE; Dombrecht EJ; Ebo DG; Bridts CH; Stevens WJ; De Clerck LS
Cell Immunol; 2008 Feb; 251(2):109-15. PubMed ID: 18538752
[TBL] [Abstract][Full Text] [Related]
17. [Elevated levels of Th17/regulatory T cells in peripheral blood are associated with disease activity of patients with rheumatoid arthritis].
Yao X; Cao Y; Ma W; Hou L; Zhong Q; Huang Y; Tang F; Xu H; Liang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jan; 31(1):81-4. PubMed ID: 25575064
[TBL] [Abstract][Full Text] [Related]
18. Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis.
van Amelsfort JM; van Roon JA; Noordegraaf M; Jacobs KM; Bijlsma JW; Lafeber FP; Taams LS
Arthritis Rheum; 2007 Mar; 56(3):732-42. PubMed ID: 17328044
[TBL] [Abstract][Full Text] [Related]
19. Role of new population of peripheral CD11c(+)CD8(+) T cells and CD4(+)CD25(+) regulatory T cells during acute and remission stages in rheumatoid arthritis patients.
Kao JK; Hsue YT; Lin CY
J Microbiol Immunol Infect; 2007 Oct; 40(5):419-27. PubMed ID: 17932602
[TBL] [Abstract][Full Text] [Related]
20. [Association of circulating Treg cells with disease activity in patients with rheumatoid arthritis].
Chen R; Tao Y; Qiu K; Huang W; Huang C; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(6):886-9. PubMed ID: 22699077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
